Register Now
Course Information

Join us for Advancing Cardiovascular Care: Current and Evolving Management Strategies 2023.

Cardiovascular (CV) medicine is a rapidly evolving discipline. Research studies and clinical trials are continually expanding the evidence base related to the assessment, diagnosis, and treatment of patients with CV disease. In addition, new technologies, new drugs, and new devices are expanding the therapeutic choices available to clinicians.

The volume and complexity of the data being generated combined with the expanded technologies make it difficult for busy CV specialists to remain up to date on knowledge of the data and the implications for clinical practice. This educational activity is designed for busy clinicians by providing a review and analysis of new research and technical advances and assessing their potential impact on management of patients in clinical practice. 

Why Attend This Symposium?

  • Hear cutting-edge updates and research on the management of cardiovascular disease
  • Earn CME and ABIM Maintenance of Certification Points
  • Learn from leading experts in the field of cardiovascular medicine and surgery
  • Explore our exhibit hall

After completing this activity, participants will be able to:

  • Define and describe current strategies for the prevention and management of hyperlipidemia, hypertension and cardiovascular protection with Type 2 diabetes.
  • Critically appraise management strategies for total occlusions, microvascular disease and outcomes for CABG for complex multi-vessel disease.
  • Critically appraise practical applications for the management of tricuspid disease and degenerative mitral regurgitation (MR), including the role of guideline-directed medical therapy (GDMT) and surgical techniques for MR.
  • Analyze the clinical applications and treatments for the management of aortic valve disease.
  • Define strategies for the management of heart failure and cardiomyopathy, including GDMT in patients with reduced ejection fraction (HFrEF), diagnosis and management of hypertrophic cardiomyopathy and selection and decision-making in left ventricular assisted devices (LVAD) and transplantation.
  • Appraise management strategies for new-onset AFib, including interventional options for stroke risk.

Who Should Attend?

The course is directed to physicians, physician assistants, nurse practitioners, and nurses with an interest in cardiovascular medicine and surgery.